NCT00129649 Service Development: Assessing Non-attendance Rates in Outpatient Clinics Status COMPLETED Phase NA
NCT00120510 Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti Status COMPLETED Phase NA
NCT00115609 Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) Status COMPLETED Phase PHASE3
NCT00108862 Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis Status COMPLETED Phase PHASE4
NCT00107887 TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) Status COMPLETED Phase PHASE4
NCT00096850 Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults Status COMPLETED Phase NA
NCT00096681 Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa Status COMPLETED Phase N/A
NCT00091936 Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings Status COMPLETED Phase NA
NCT00082173 Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis Status COMPLETED Phase PHASE2
NCT00080119 Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV Status TERMINATED Phase PHASE2/PHASE3
NCT00078247 Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis Status COMPLETED Phase PHASE3
NCT00052195 Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People Status COMPLETED Phase PHASE2/PHASE3
NCT00023452 Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection Status COMPLETED Phase PHASE3
NCT00023439 TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment Status COMPLETED Phase N/A
NCT00023426 TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis Status COMPLETED Phase PHASE2